Medical News

RSS

Study: GSTP gene protects against bowel cancer

CANCER RESEARCH UK scientists have shown that deleting a single gene can increase the average number of tumours in the bowel by 50-fold, according to research published in PNAS today.

25 Nov 2009

FDA provides marketing clearance for Prodesse's ProParaflu+ assay

Gen-Probe Incorporated announced today that the US Food and Drug Administration (FDA) has cleared for marketing Prodesse's ProParaflu+(TM) assay, a molecular test that detects and differentiates parainfluenza 1, 2 and 3 viruses, which cause lower respiratory tract infections.

25 Nov 2009

Alpha-fetoprotein, a well-tolerated agent for treatment and prevention of breast cancer

Researchers have found that hormones produced during pregnancy induce a protein that directly inhibits the growth of breast cancer. This protein, alpha-fetoprotein (AFP), may serve as a viable, well-tolerated agent for the treatment and prevention of breast cancer, according to findings published in Cancer Prevention Research, a journal of the American Association for Cancer Research.

25 Nov 2009

Pharmaceutical research and biotechnology companies test medicines and vaccines to treat HIV/AIDS

America's pharmaceutical research and biotechnology companies are testing 97 medicines and vaccines to treat or prevent HIV/AIDS and related conditions, according to a new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA).

25 Nov 2009

IQWiG calls for mandatory registration and publication of all clinical trial results

Today the Institute for Quality and Efficiency in Health Care (IQWiG) is calling for registration and publication of the results of all clinical trials to be made obligatory.

25 Nov 2009

EMEA grants orphan drug status for LFB Biotechnologies' recombinant anti-CD20 monoclonal antibody

The recombinant anti-CD20 monoclonal antibody produced by LFB Biotechnologies received orphan drug status for the treatment of Chronic Lymphocytic Leukemia (CLL). This approval from the EMEA’s Committee for Orphan Medicinal Products (COMP) was handed down on last October 7th.

25 Nov 2009

Researchers develop new device to detect skin cancer

Researchers at Ben-Gurion University of the Negev are developing a new device that detects cancerous skin tumors, including melanomas that aren't visible to the naked eye.

25 Nov 2009

Community-based program proves to be successful in reducing skin infections in Australian aboriginal children

A community-based program aimed at reducing the burden of skin disease across remote communities in Australia's Northern Territory has been successful according to a study published November 24 in the open-access journal PLoS Neglected Tropical Diseases.

25 Nov 2009

Anthem members in Bangor and Presque Isle can now visit their physician without leaving home

Thanks to an innovative program recently developed between Eastern Maine Healthcare Systems (EMHS) and Anthem Blue Cross and Blue Shield in Maine, some Anthem members in Bangor and Presque Isle can now "visit" their physician without leaving home.

25 Nov 2009

MedLink International announces its participation in Health Information Technology Extension Program

MedLink International, Inc. (OTCBB: MLKNA) announced today that it will participate in the Health Information Technology Extension Program. The extension program consists of Regional Extension Centers and a national Health Information Technology Research Center (HITRC).

25 Nov 2009

Study finds no significant difference in hospital angioplasty volume and death rates in patients with myocardial infarction

A study based on a contemporary registry of patients with myocardial infarction (heart attack) indicates that even though hospitals that perform a higher number of angioplasties are more likely to follow evidence-based guidelines and have shorter times to the angioplasty procedure, there appears to be no significant difference in outcomes such as length of hospital stay or risk of death, according to a study in the November 25 issue of JAMA.

25 Nov 2009

Older adults with chronic musculoskeletal pain face increase risk for falls

Older adults who reported chronic musculoskeletal pain in two or more locations, higher levels of severe pain, or pain that interfered with daily activities were more likely to experience a fall than adults who did not reports these types of pain, according to a study in the November 25 issue of JAMA.

25 Nov 2009

Study shows 95 percent of radiation oncologists use FDG-PET, MRI and 4DCT to locate cancer

A recent study shows that 95 percent of radiation oncologists use advanced imaging techniques such as positron emission tomography (FDG-PET), magnetic resonance imaging (MRI), and 4-dimensional computed tomography (4DCT) for target delineation (to locate the tumor and other areas at risk for having cancer), according to an article in the December issue of the Journal of the American College of Radiology, (JACR, www.jacr.org).

25 Nov 2009

Incyte enters into collaboration and license agreement with Novartis

Incyte Corporation (NASDAQ: INCY) announced today that it has entered into a collaboration and license agreement with Novartis for two of its investigational hematology-oncology therapies: INCB18424, an oral JAK1/JAK2 inhibitor that is in Phase III development for myelofibrosis, a serious life-threatening neoplastic condition characterized by varying degrees of bone marrow failure, splenic enlargement and debilitating constitutional symptoms, and INCB28060, an oral cMET inhibitor that is about to enter Phase I development as a potential treatment for multiple cancers.

25 Nov 2009

Initiation of Phase II clinical trial to evaluate the efficacy of BN83495 announced

Ipsen today announced the initiation of an international, multi-center, controlled, randomized Phase II clinical trial to evaluate the safety and efficacy of BN83495, its investigational first-in-class steroid sulfatase (STS) inhibitor, in advanced endometrial cancer.

25 Nov 2009

Multiple presentations from clinical and preclinical studies of ISTODAX to be presented

Gloucester Pharmaceuticals today announced multiple presentations from clinical and preclinical studies of ISTODAX® (romidepsin) at the upcoming 51st American Society of Hematology (ASH) Annual Meeting being held in New Orleans, Louisiana, at the Ernest N. Morial Convention Center, December 5 – 8, 2009.

25 Nov 2009

New York Imaging Service becomes an authorized distributor of Quix Plasma DR digital detector

EDGE Medical Devices today announced that New York Imaging Service has become an authorized distributor of the Quix™ Plasma DR™ digital detector and Universal Retrofit Kit.

25 Nov 2009

Eisai's NDA for Aricept tablets for treatment of Alzheimer's disease accepted for review

Eisai Inc. and Pfizer Inc announced today that the U.S. Food and Drug Administration (FDA) has accepted for review Eisai's New Drug Application (NDA) for once daily 23 mg Aricept® (donepezil HCl extended release) tablets for the treatment of moderate to severe Alzheimer's disease (AD).

25 Nov 2009

Springer and ACMT collaborate to publish ‘Journal of Medical Toxicology’

Springer and the American College of Medical Toxicology (ACMT) have signed an agreement to collaborate on the publication of the Journal of Medical Toxicology (JMT), the official journal of the ACMT, beginning in March 2010. It was previously published by the University of Pennsylvania Press.

25 Nov 2009

AssistMed implements InterSystems Ensemble rapid integration and development platform for its EHR system

InterSystems Corporation today announced that AssistMed, Inc. has chosen the InterSystems Ensemble® rapid integration and development platform to provide integration capability for its AssistMed EHR.

25 Nov 2009

Medical News

Study: GSTP gene protects against bowel cancer

FDA provides marketing clearance for Prodesse's ProParaflu+ assay

Alpha-fetoprotein, a well-tolerated agent for treatment and prevention of breast cancer

Pharmaceutical research and biotechnology companies test medicines and vaccines to treat HIV/AIDS

IQWiG calls for mandatory registration and publication of all clinical trial results

EMEA grants orphan drug status for LFB Biotechnologies' recombinant anti-CD20 monoclonal antibody

Researchers develop new device to detect skin cancer

Community-based program proves to be successful in reducing skin infections in Australian aboriginal children

Anthem members in Bangor and Presque Isle can now visit their physician without leaving home

MedLink International announces its participation in Health Information Technology Extension Program

Study finds no significant difference in hospital angioplasty volume and death rates in patients with myocardial infarction

Older adults with chronic musculoskeletal pain face increase risk for falls

Study shows 95 percent of radiation oncologists use FDG-PET, MRI and 4DCT to locate cancer

Incyte enters into collaboration and license agreement with Novartis

Initiation of Phase II clinical trial to evaluate the efficacy of BN83495 announced

Multiple presentations from clinical and preclinical studies of ISTODAX to be presented

New York Imaging Service becomes an authorized distributor of Quix Plasma DR digital detector

Eisai's NDA for Aricept tablets for treatment of Alzheimer's disease accepted for review

Springer and ACMT collaborate to publish ‘Journal of Medical Toxicology’

AssistMed implements InterSystems Ensemble rapid integration and development platform for its EHR system

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News